Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Andrew Troger"'
Autor:
Yi Wei, Andrew Troger, Viola Spahiu, Natalia Perekhvatova, Maxim Skulachev, Anton Petrov, Boris Chernyak, Penny Asbell
Publikováno v:
Ophthalmology and Therapy, Vol 8, Iss 1, Pp 63-73 (2018)
Abstract Introduction SkQ1 (Visomitin) is a novel mitochondrial-targeted antioxidant that holds promise in the treatment of inflammation associated with ocular surface diseases such as dry eye disease (DED) and corneal wounds. However, the specific r
Externí odkaz:
https://doaj.org/article/aa95740a36d64083a402f2e5ad2f2b5a
Autor:
Andrew Troger, Michele Burns
Publikováno v:
Visual Journal of Emergency Medicine. 31:101647
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04b33f0acb834f124af4d1cbcd0aadaa
https://doi.org/10.1016/j.visj.2023.101647
https://doi.org/10.1016/j.visj.2023.101647
Autor:
Andrew Troger, Anton Petrov, Natalia Perekhvatova, Viola Spahiu, Maxim V. Skulachev, Penny A. Asbell, Yi Wei, Boris V. Chernyak
Publikováno v:
Ophthalmology and Therapy, Vol 8, Iss 1, Pp 63-73 (2018)
Ophthalmology and Therapy
Ophthalmology and Therapy
Introduction SkQ1 (Visomitin) is a novel mitochondrial-targeted antioxidant that holds promise in the treatment of inflammation associated with ocular surface diseases such as dry eye disease (DED) and corneal wounds. However, the specific role of Sk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e6d5874eccf3e6433f660381cde52d
https://doi.org/10.1007/s40123-018-0158-2
https://doi.org/10.1007/s40123-018-0158-2